Back
Speaker illustration

Professor Young-Hoon Jeong

Chung-Ang University Gwangmyeong Hospital, Gwangmyeong (Korea (Republic of))

Member of:

European Society of Cardiology

Dr. Young-Hoon Jeong is a distinguished cardiologist and professor affiliated with Chung-Ang University Gwang-Myeong Hospital and works as a director in CAU Thrombosis and Biomarker Center in Gwang-Myeong, South Korea. He earned his MD and PhD degrees and has been recognized as a Fellow of both the American Heart Association (FAHA) and the European Society of Cardiology (FESC).​ Throughout his career, Dr. Jeong has contributed extensively to the field of antithrombotic therapy, particularly concerning its application in East Asian patients with acute coronary syndrome or those undergoing percutaneous coronary intervention. His research emphasizes the importance of considering racial differences in drug metabolism and response to optimize treatment outcomes.

Presentations Articles

Clinical significance of time-varying on-treatment platelet reactivity after percutaneous coronary intervention

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Platelets and more

Access
Like
Thumbnail

Relationship between serial c-reactive protein levels and cardiovascular events in East asian patients treated with percutaneous coronary intervention

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Best Posters in new insights in the assessment of the long-term risk in coronary disease

Access
Like
Thumbnail

Influence of amlodipine on antiplatelet effect of clopidogrel in patients treated with percutaneous coronary intervention: result of the randomized, prospective, two-period, crossover, ACCEL-CCB trial

Event: ESC Congress 2017

Topic: Thrombosis and platelets

Session: Best Posters in antiplatelet agents in acute coronary syndromes

Access
Like
Thumbnail

A randomised, double-blind, placebo controlled trial to evaluate the effect of adjunctive cilostazol on endothelial progenitor cell mobilization in AMI patients: the result of the ACCEL-EPISODE trial

Event: ESC Congress 2016

Topic: Adjunctive medical therapy

Session: Adjunctive medical therapy in coronary artery disease

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources